Physician profile
Mark Wilson
NPI 1003132754
$1,388.38
in general payments reported to CMS, 2019-2025
13 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.99 · 2020: $28.52 · 2021: $67.88 · 2022: $94.11 · 2023: $534 · 2024: $432 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $477.67 | 2021-2025 | Qelbree, Qelbree |
| Mckesson Medical-Surgical, INC. | $247.83 | 2022-2025 | |
| Glaxosmithkline, LLC. | $206.80 | 2019-2024 | Bexsero |
| Corium, LLC | $143.98 | 2021-2025 | Azstarys |
| Pfizer INC. | $97.34 | 2019-2024 | |
| Ironshore Pharmaceuticals INC. | $54.02 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $53.21 | 2022-2024 | Gardasil 9, Proquad, Vaxneuvance |
| Becton, Dickinson and Company | $34.49 | 2022 | |
| Adlon Therapeutics L.P. | $17.08 | 2020 | |
| Collegium Pharmaceutical, INC. | $16.73 | 2025 | Jornay Pm |
| Kowa Pharmaceuticals America, INC. | $14.58 | 2025 | Zoryve |
| Kyowa Kirin, INC. | $13.00 | 2023 | Crysvita |
| Sanofi Pasteur INC. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.